Colistin is considered a last-resort antimicrobial for treatment of infections with multidrug-resistant bacteria, classified by the World Health Organization (WHO) as ‘highest prioritized, critically important for human medicine’.
With funding from IDRC, a research team from the Prospective Urban Rural Epidemiology (PURE) study, a large international population research effort coordinated by McMaster University’s Population Health Research Institute (PHRI), is studying why some people get COVID-19 and others do not.
In countries across Southeast Asia, poor and marginalized populations face a series of justice gaps due to poor awareness of their rights as well as barriers to accessing the complex, formalistic, slow, and expensive legal mechanisms to enforce those rights.
As part of IDRC’s Think Climate Indonesia initiative (TCI), a virtual inception workshop was held on July 21, 22 and 27, 2021, for the five project partners -- Yayasan INOBU, WRI–Indonesia, PATTIRO, Yayasan Kota Kita, and Kemitraan. Organized by IDRC’s TCI project manager and a team of facilitators from Inclusive Innovation, the workshop focused on team building, strategy building, and capacity building.
A number of countries and international organizations have stressed the need for integrated surveillance systems to comprehensively detect and monitor antimicrobial resistance (AMR), particularly in animal and environmental reservoirs.
According to the United Nations Economic and Social Commission for Asia and the Pacific, Southeast Asia has been experiencing more frequent climate-related disaster events and an exponential increase in annual deaths for the past thirty years.